Monika Głuch-Lutwin Selected Research

Hypnotics and Sedatives (Sedatives)

1/2018

Evaluation of anticonvulsant and analgesic activity of new hybrid compounds derived from N-phenyl-2-(2,5-dioxopyrrolidin-1-yl)-propanamides and -butanamides.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monika Głuch-Lutwin Research Topics

Disease

7	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 11/2016
3	Dementia (Dementias) 04/2022 - 01/2017
3	Cognitive Dysfunction 04/2020 - 01/2017
3	Body Weight (Weight, Body) 01/2017 - 01/2015
2	Chronic Pain 05/2022 - 01/2018
2	Memory Disorders (Memory Loss) 04/2022 - 01/2017
2	Inflammation (Inflammations) 01/2019 - 01/2017
2	Hyperalgesia 01/2018 - 01/2017
2	Neuralgia (Stump Neuralgia) 01/2018 - 01/2018
2	Obesity 04/2016 - 01/2015
1	Non-alcoholic Fatty Liver Disease 02/2024
1	Psychotic Disorders (Schizoaffective Disorder) 11/2023
1	Neuroinflammatory Diseases 04/2023
1	Mental Disorders (Mental Disorder) 01/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023
1	Anhedonia 01/2023
1	Catalepsy 12/2022
1	Ataxia (Dyssynergia) 12/2022
1	Asthma (Bronchial Asthma) 01/2021
1	Allergic Rhinitis 01/2021
1	Colitis 01/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Pruritus (Itching) 01/2021
1	Central Nervous System Diseases (CNS Diseases) 01/2021
1	Schizophrenia (Dementia Praecox) 08/2020
1	Epilepsy (Aura) 08/2020
1	Pain (Aches) 01/2018
1	Seizures (Absence Seizure) 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Peritonitis 01/2017
1	Edema (Dropsy) 01/2017
1	Hypoglycemia (Reactive Hypoglycemia) 01/2016
1	Anxiety Disorders (Anxiety Disorder) 01/2016
1	Orthostatic Hypotension (Postural Hypotension) 01/2016
1	Hypertension (High Blood Pressure) 01/2015
1	Conduct Disorder (Conduct Disorders) 01/2015
1	Diabetic Neuropathies (Diabetic Neuropathy) 03/2014
1	Hepatocellular Carcinoma (Hepatoma) 03/2014

Drug/Important Bio-Agent (IBA)

7	LigandsIBA 11/2023 - 01/2015
5	LipidsIBA 02/2024 - 03/2014
4	Antipsychotic Agents (Antipsychotics)IBA 12/2022 - 01/2017
4	Antidepressive Agents (Antidepressants)IBA 04/2022 - 01/2016
3	Serotonin (5 Hydroxytryptamine)IBA 11/2023 - 04/2022
3	Anti-Anxiety Agents (Anxiolytics)IBA 12/2022 - 01/2017
3	Anticonvulsants (Antiepileptic Drugs)IBA 08/2020 - 01/2018
3	Analgesics (Analgesic Drugs)IBA 01/2018 - 03/2014
3	Glucose (Dextrose)FDA LinkGeneric 04/2016 - 03/2014
2	Histamine H4 ReceptorsIBA 01/2021 - 01/2017
2	AntioxidantsIBA 12/2019 - 03/2014
2	CarrageenanIBA 01/2019 - 01/2017
2	Formaldehyde (Formol)FDA Link 01/2019 - 01/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 01/2018
2	HBK-15IBA 01/2017 - 01/2016
2	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2016 - 01/2015
2	Glycerol (Glycerine)FDA LinkGeneric 04/2016 - 01/2015
1	SeleniumIBA 01/2024
1	Serotonin ReceptorsIBA 01/2024
1	Ether (Diethyl Ether)IBA 11/2023
1	TriazinesIBA 11/2023
1	GABA-A Receptors (GABA(A) Receptor)IBA 04/2023
1	salicylamideIBA 01/2023
1	Dopamine (Intropin)FDA LinkGeneric 01/2023
1	Sucrose (Saccharose)IBA 01/2023
1	XanthineIBA 01/2023
1	Amphetamine (Amfetamine)FDA LinkGeneric 12/2022
1	Morphine (MS Contin)FDA LinkGeneric 05/2022
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 04/2022
1	5-HT1A Serotonin ReceptorIBA 01/2021
1	compound 18IBA 08/2020
1	Pentylenetetrazole (Metrazol)IBA 08/2020
1	BenzoxazolesIBA 04/2020
1	Quetiapine Fumarate (Seroquel)FDA Link 04/2020
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 12/2019
1	LipopolysaccharidesIBA 12/2019
1	Cholinesterases (Cholinesterase)IBA 12/2019
1	Calcium Channels (Calcium Channel)IBA 12/2019
1	pyrrolidine-2,5-dioneIBA 01/2018
1	Streptozocin (Streptozotocin)FDA Link 01/2018
1	Hypnotics and Sedatives (Sedatives)IBA 01/2018
1	Scopolamine (Hyoscine)FDA Link 01/2017
1	Nerve Growth Factor (NGF)IBA 01/2017
1	ZymosanIBA 01/2017
1	CorticosteroneIBA 01/2017
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2017
1	serotonin 6 receptorIBA 11/2016
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 11/2016
1	Blood Glucose (Blood Sugar)IBA 04/2016
1	HBK-14IBA 01/2016
1	Yohimbine (Yocon)IBA 01/2015
1	Guanfacine (Tenex)FDA LinkGeneric 01/2015
1	Appetite Depressants (Anorectics)IBA 01/2015
1	AcidsIBA 03/2014
1	Indicators and Reagents (Reagents)IBA 03/2014
1	Dithionitrobenzoic Acid (Ellman's Reagent)IBA 03/2014

Therapy/Procedure

6	Therapeutics 01/2023 - 11/2016
1	Drug Therapy (Chemotherapy) 01/2018
1	Analgesia 03/2014